Global regulatory guidelines fail to mandate a standard rat strain for carcinogenicity studies; therefore, selecting the optimal strain can be a challenge. In our latest white paper, we explore the numerous advantageous features of the Wistar Han rat when it comes to toxicology studies.
These features can translate to superior long-term study outcomes, better adherence to the Three R’s, and cost savings. Overall, there’s strong regulatory precedent for use of the Wistar Han rat in nonclinical toxicology assessments, including two-year carcinogenicity studies.
Download today and understand:
- Wistar Han rat origins and applications
- Regulatory precedent for use of this strain
- Historical control data points
- Factors to consider when selecting a rat model
